Marinus Pharmaceuticals I... (MRNS)
NASDAQ: MRNS
· Real-Time Price · USD
0.55
0.00 (0.00%)
At close: Feb 10, 2025, 3:59 PM
Marinus Pharmaceuticals Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|
| Collaboration revenue Revenue | 17K | 18K | 18K | 36K | 18K | 18K | 3M | 555K |
| Collaboration revenue Revenue Growth | -5.56% | 0.00% | -50.00% | +100.00% | 0.00% | -99.40% | +440.18% | n/a |
| Product Revenue | 8.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Product Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 12.57M | 16.71M | 18.63M | 15.36M | 14.87M | 15.72M | 15.2M | 14.66M | 13.39M | 17.06M | 11.74M | 10.62M | 9.45M | 6.83M | 10.38M | 6M | 4.56M | 4.13M | 3.85M | 2.96M | 2.33M | 2.5M | 3.67M | 2.19M | 2.07M | 2.34M | 2.19M | 1.59M | 1.57M | 1.69M | 1.81M | 1.52M | 1.53M | 1.59M | 1.6M | 1.44M | 1.38M | 1.25M | 1.45M |
| Selling, General, and Administrative Revenue Growth | -24.76% | -10.29% | +21.28% | +3.30% | -5.43% | +3.41% | +3.72% | +9.48% | -21.52% | +45.36% | +10.50% | +12.38% | +38.43% | -34.19% | +72.79% | +31.57% | +10.51% | +7.27% | +30.07% | +27.20% | -6.99% | -31.77% | +67.75% | +5.45% | -11.33% | +6.90% | +37.29% | +1.40% | -7.10% | -6.68% | +19.37% | -0.72% | -3.59% | -1.12% | +11.23% | +4.64% | +9.80% | -13.27% | n/a |
| Research and Development Revenue | 16.33M | 20.9M | 23.99M | 26.26M | 23.66M | 21.41M | 27.93M | 21.42M | 19M | 21.5M | 17.99M | 18.01M | 18.35M | 18.56M | 18.59M | 13.04M | 11.31M | 11.75M | 15M | 12.51M | 11.57M | 10.01M | 8.87M | 8.09M | 9.15M | 7.23M | 3.93M | 3.34M | 2.64M | 2.82M | 3.57M | 4.41M | 4.84M | 7.26M | 5.49M | 6.06M | 3.47M | 3.92M | 5.47M |
| Research and Development Revenue Growth | -21.84% | -12.88% | -8.65% | +10.97% | +10.50% | -23.35% | +30.38% | +12.75% | -11.60% | +19.48% | -0.13% | -1.85% | -1.13% | -0.16% | +42.53% | +15.37% | -3.80% | -21.67% | +19.92% | +8.12% | +15.60% | +12.83% | +9.71% | -11.60% | +26.49% | +84.16% | +17.43% | +26.57% | -6.21% | -21.16% | -19.02% | -8.84% | -33.31% | +32.11% | -9.34% | +74.54% | -11.32% | -28.40% | n/a |